Enterocyte glycosylation is responsive to changes in extracellular conditions: implications for membrane functions

Glycobiology

Volumn 27, Issue 9, 2017, Pages 847-860

  Park, Dayoung ^a   Xu, Gege ^a   Barboza, Mariana ^a   Shah, Ishita M ^a   Wong, Maurice ^a   Raybould, Helen ^a   Mills, David A ^a   Lebrilla, Carlito B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell biology; Glycosylation; Mass spectrometry; Membrane proteins; Metabolism

Indexed keywords

ALKALOID; ENZYME INHIBITOR; FRUCTOSE; FUCOSE; GALACTOSE; GLUTAMINE; KIFUNENSINE; MANNOSE; MANNOSIDASE; VOLATILE FATTY ACID;

ANTAGONISTS AND INHIBITORS; CACO-2 CELL LINE; CARBOHYDRATE ANALYSIS; CELL MEMBRANE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; GLYCOBIOLOGY; GLYCOSYLATION; HT-29 CELL LINE; HUMAN; METABOLISM;

ALKALOIDS; CACO-2 CELLS; CARBOHYDRATE SEQUENCE; CELL MEMBRANE; ENZYME INHIBITORS; FATTY ACIDS, VOLATILE; FRUCTOSE; FUCOSE; GALACTOSE; GLUTAMINE; GLYCOMICS; GLYCOSYLATION; HT29 CELLS; HUMANS; MANNOSE; MANNOSIDASES;

EID: 85031894615     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwx041     Document Type: Article

References (66)

1. Adibi SA, Mercer DW. 1973. Protein digestion in human intestine as reflected in luminal, mucosal, and plasma amino acid concentrations after meals. J Clin Invest. 52:1586–1594.
2. Aebi M, Bernasconi R, Clerc S, Molinari M. 2010. N-glycan structures: Recognition and processing in the ER. Trends Biochem Sci. 35:74–82.
3. An HJ, Gip P, Kim J, Wu S, Park KW, McVaugh CT, Schaffer DV, Bertozzi CR, Lebrilla CB. 2012. Extensive determination of glycan heterogeneity reveals an unusual abundance of high mannose glycans in enriched plasma membranes of human embryonic stem cells. Mol Cell Proteomics. 11: M111.010660.
4. Blachier F, Boutry C, Bos C, Tome D. 2009. Metabolism and functions of L-glutamate in the epithelial cells of the small and large intestines. Am J Clin Nutr. 90:814S–821S.
5. Briske-Anderson MJ, Finley JW, Newman SM. 1997. The influence of culture time and passage number on the morphological and physiological development of Caco-2 cells. Proc Soc Exp Biol Med. 214:248–257.
6. Brymora A, Flisinski M, Johnson RJ, Goszka G, Stefanska A, Manitius J. 2012. Low-fructose diet lowers blood pressure and inflammation in patients with chronic kidney disease. Nephrol Dial Transplant. 27:608–612.
7. Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A, Rousset M. 1994. Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: Evidence for glucose-dependent negative regulation. J Cell Sci. 107(Pt 1):213–225.
8. Correa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA. 2016. Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunol. 5:e73.
9. Cumming DA. 1991. Glycosylation of recombinant protein therapeutics: Control and functional implications. Glycobiology. 1:115–130.
10. Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT. 1987. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 28:1221–1227.
11. De-Souza DA, Greene LJ. 2005. Intestinal permeability and systemic infections in critically ill patients: Effect of glutamine. Crit Care Med. 33: 1125–1135.
12. DeBerardinis RJ, Cheng T. 2010. Q’s next: The diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene. 29:313–324.
13. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 54:2325–2340.
14. Du J, Meledeo MA, Wang Z, Khanna HS, Paruchuri VD, Yarema KJ. 2009. Metabolic glycoengineering: Sialic acid and beyond. Glycobiology. 19: 1382–1401.
15. Elliott S, Lorenzini T, Asher S, Aoki K, Brankow D, Buck L, Busse L, Chang D, Fuller J, Grant J, et al. 2003. Enhancement of therapeutic protein in vivo activities through glycoengineering. Nat Biotechnol. 21:414–421.
16. Fallingborg J. 1999. Intraluminal pH of the human gastrointestinal tract. Dan Med Bull. 46:183–196.
17. Ferraris RP, Yasharpour S, Lloyd KCK, Mirzayan R, Diamond JM. 1990. Luminal glucose-concentrations in the gut under normal conditions. Am J Physiol. 259:G822–G837.
18. Gawlitzek M, Ryll T, Lofgren J, Sliwkowski MB. 2000. Ammonium alters N-glycan structures of recombinant TNFR-IgG: Degradative versus biosynthetic mechanisms. Biotechnol Bioeng. 68:637–646.
19. Goto Y, Obata T, Kunisawa J, Sato S, Ivanov II, Lamichhane A, Takeyama N, Kamioka M, Sakamoto M, Matsuki T, et al. 2014. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science. 345:1254009.
20. Ha TK, Lee GM. 2014. Effect of glutamine substitution by TCA cycle intermediates on the production and sialylation of Fc-fusion protein in Chinese hamster ovary cell culture. J Biotechnol. 180:23–29.
21. Helenius A, Aebi M. 2001. Intracellular functions of N-linked glycans. Science. 291:2364–2369.
22. Hilgers AR, Conradi RA, Burton PS. 1990. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res. 7: 902–910.
23. Hua S, An HJ, Ozcan S, Ro GS, Soares S, DeVere-White R, Lebrilla CB. 2011. Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkers. Analyst (Lond). 136: 3663–3671.
24. Hudak JE, Yu HH, Bertozzi CR. 2011. Protein glycoengineering enabled by the versatile synthesis of aminooxy glycans and the genetically encoded aldehyde tag. J Am Chem Soc. 133:16127–16135.
25. Ichikawa M, Scott DA, Losfeld ME, Freeze HH. 2014. The metabolic origins of mannose in glycoproteins. J Biol Chem. 289:6751–6761.
26. Jones DP, Coates RJ, Flagg EW, Eley JW, Block G, Greenberg RS, Gunter EW, Jackson B. 1992. Glutathione in foods listed in the National Cancer Institute’s Health Habits and History Food Frequency Questionnaire. Nutr Cancer. 17:57–75.
27. Kato Y, Ozawa S, Miyamoto C, Maehata Y, Suzuki A, Maeda T, Baba Y. 2013. Acidic extracellular microenvironment and cancer. Cancer Cell Int. 13:89.
28. Keppler OT, Hinderlich S, Langner J, Schwartz-Albiez R, Reutter W, Pawlita M. 1999. UDP-GlcNAc 2-epimerase: A regulator of cell surface sialylation. Science. 284:1372–1376.
29. Kirchner S, Muduli A, Casirola D, Prum K, Douard V, Ferraris RP. 2008. Luminal fructose inhibits rat intestinal sodium-phosphate cotransporter gene expression and phosphate uptake. Am J Clin Nutr. 87:1028–1038.
30. Klein A, Roussel P. 1998. O-acetylation of sialic acids. Biochimie. 80:49–57.
31. Klimberg VS, Salloum RM, Kasper M, Plumley DA, Dolson DJ, Hautamaki RD, Mendenhall WR, Bova FC, Bland KI, Copeland EM3rd, et al. 1990. Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg. 125:1040–1045.
32. Kronewitter SR, An HJ, de Leoz ML, Lebrilla CB, Miyamoto S, Leiserowitz GS. 2009. The development of retrosynthetic glycan libraries to profile and classify the human serum N-linked glycome. Proteomics. 9:2986–2994.
33. Lai K, Elsas LJ, Wierenga KJ. 2009. Galactose toxicity in animals. IUBMB life. 61:1063–1074.
34. Marcobal A, Southwick AM, Earle KA, Sonnenburg JL. 2013. A refined palate: Bacterial consumption of host glycans in the gut. Glycobiology. 23: 1038–1046.
35. Moran AP, Gupta A, Joshi L. 2011. Sweet-talk: Role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut. 60:1412–1425.
36. Moremen KW, Tiemeyer M, Nairn AV. 2012. Vertebrate protein glycosylation: Diversity, synthesis and function. Nat Rev Mol Cell Biol. 13:448–462.
37. Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Odum N, et al. 2015. The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep. 5:16148.
38. Newsholme P, Lima MM, Procopio J, Pithon-Curi TC, Doi SQ, Bazotte RB, Curi R. 2003. Glutamine and glutamate as vital metabolites. Braz J Med Biol Res. 36:153–163.
39. O’Connor SE, Imperiali B. 1996. Modulation of protein structure and function by asparagine-linked glycosylation. Chem Biol. 3:803–812.
40. Oetke C, Hinderlich S, Brossmer R, Reutter W, Pawlita M, Keppler OT. 2001. Evidence for efficient uptake and incorporation of sialic acid by eukaryotic cells. Eur J Biochem. 268:4553–4561.
41. Orlando R, Lim JM, Atwood JA3rd, Angel PM, Fang M, Aoki K, Alvarez-Manilla G, Moremen KW, York WS, Tiemeyer M, et al. 2009. IDAWG: Metabolic incorporation of stable isotope labels for quantitative glyco-mics of cultured cells. J Proteome Res. 8:3816–3823.
42. Ovesen L, Bendtsen F, Tage-Jensen U, Pedersen NT, Gram BR, Rune SJ. 1986. Intraluminal pH in the stomach, duodenum, and proximal jejunum in normal subjects and patients with exocrine pancreatic insufficiency. Gastroenterology. 90:958–962.
43. Paradise RK, Lauffenburger DA, Van Vliet KJ. 2011. Acidic extracellular pH promotes activation of integrin alpha(v)beta(3). PLoS One. 6:e15746.
44. Park D, Arabyan N, Williams CC, Song T, Mitra A, Weimer BC, Maverakis E, Lebrilla CB. 2016. Salmonella typhimurium enzymatically landscapes the host intestinal epithelial cell (IEC) surface glycome to increase invasion. Mol Cell Proteomics. 15:3653–3664.
45. Park D, Brune KA, Mitra A, Marusina AI, Maverakis E, Lebrilla CB. 2015. Characteristic changes in cell surface glycosylation accompany intestinal epithelial cell (IEC) differentiation: High mannose structures dominate the cell surface glycome of undifferentiated enterocytes. Mol Cell Proteomics. 14:2910–2921.
46. Parry S, Hanisch FG, Leir SH, Sutton-Smith M, Morris HR, Dell A, Harris A. 2006. N-Glycosylation of the MUC1 mucin in epithelial cells and secretions. Glycobiology. 16:623–634.
47. Pickard JM, Maurice CF, Kinnebrew MA, Abt MC, Schenten D, Golovkina TV, Bogatyrev SR, Ismagilov RF, Pamer EG, Turnbaugh PJ, et al. 2014. Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature. 514:638–641.
48. Pinto M, Robineleon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simonassmann P, Haffen K, Fogh J, et al. 1983. Enterocyte-like differentiation and polarization of the human-colon carcinoma cell-line Caco-2 in culture. Biol Cell. 47:323–330.
49. Pye G, Evans DF, Ledingham S, Hardcastle JD. 1990. Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. Gut. 31:1355–1357.
50. Rasmussen JR. 1992. Effect of glycosylation on protein function. Curr Opin Struct Biol. 2:682–686.
51. Rayssiguier Y, Gueux E, Nowacki W, Rock E, Mazur A. 2006. High fructose consumption combined with low dietary magnesium intake may increase the incidence of the metabolic syndrome by inducing inflammation. Magnes Res. 19:237–243.
52. Rofstad EK, Mathiesen B, Kindem K, Galappathi K. 2006. Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice. Cancer Res. 66:6699–6707.
53. Rousset M. 1986. The human colon carcinoma cell lines HT-29 and Caco-2: Two in vitro models for the study of intestinal differentiation. Biochimie. 68:1035–1040.
54. Ruhaak LR, Miyamoto S, Kelly K, Lebrilla CB. 2012. N-Glycan profiling of dried blood spots. Anal Chem. 84:396–402.
55. Ruhaak LR, Taylor SL, Miyamoto S, Kelly K, Leiserowitz GS, Gandara D, Lebrilla CB, Kim K. 2013. Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses. Anal Bioanal Chem. 405:4953–4958.
56. Sackstein R. 2012. Glycoengineering of HCELL, the human bone marrow homing receptor: Sweetly programming cell migration. Ann Biomed Eng. 40:766–776.
57. Snider MD. 2002. Metabolic labeling of glycoproteins with radioactive sugars. Curr Protoc Cell Biol. Chapter 7:Unit 7.8.
58. Souba WW, Klimberg VS, Plumley DA, Salloum RM, Flynn TC, Bland KI, Copeland EM3rd. 1990. The role of glutamine in maintaining a healthy gut and supporting the metabolic response to injury and infection. J Surg Res. 48:383–391.
59. Stierum R, Gaspari M, Dommels Y, Ouatas T, Pluk H, Jespersen S, Vogels J, Verhoeckx K, Groten J, van Ommen B. 2003. Proteome analysis reveals novel proteins associated with proliferation and differentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta. 1650:73–91.
60. Stowell SR, Ju T, Cummings RD. 2015. Protein glycosylation in cancer. Annu Rev Pathol. 10:473–510.
61. Tailford LE, Crost EH, Kavanaugh D, Juge N. 2015. Mucin glycan foraging in the human gut microbiome. Front Genet. 6:81.
62. van der Hulst RR, van Kreel BK, von Meyenfeldt MF, Brummer RJ, Arends JW, Deutz NE, Soeters PB. 1993. Glutamine and the preservation of gut integrity. Lancet. 341:1363–1365.
63. Varki A, Cummings RD, Aebi M, Packer NH, Seeberger PH, Esko JD, Stanley P, Hart G, Darvill A, Kinoshita T, et al. 2015. Symbol nomenclature for graphical representations of glycans. Glycobiology. 25: 1323–1324.
64. Vermeulen MA, de Jong J, Vaessen MJ, van Leeuwen PA, Houdijk AP. 2011. Glutamate reduces experimental intestinal hyperpermeability and facilitates glutamine support of gut integrity. World J Gastroenterol. 17: 1569–1573.
65. Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. 2006. Colonic health: Fermentation and short chain fatty acids. J Clin Gastroenterol. 40:235–243.
66. Wurm FM. 2004. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 22:1393–1398.